stoxline Quote Chart Rank Option Currency Glossary
  
(SCPH)
  0 (0%)    09-27 09:27
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:51:14 PM
Short term     
Mid term     
Targets 6-month :  6.59 1-year :  7.7
Resists First :  5.65 Second :  6.59
Pivot price 5.62
Supports First :  4.98 Second :  4.57
MAs MA(5) :  5.63 MA(20) :  5.6
MA(100) :  4.5 MA(250) :  3.82
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  81.5 D(3) :  83
RSI RSI(14): 63.7
52-week High :  6.28 Low :  1.94
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SCPH ] has closed below upper band by 6.5%. Bollinger Bands are 94.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.66 - 5.69 5.69 - 5.72
Low: 5.53 - 5.58 5.58 - 5.62
Close: 5.59 - 5.65 5.65 - 5.71
Company Description

Headline News

Sat, 27 Sep 2025
What analysts say about SCPH stock - Volatility Trading Techniques & Plan Your Future With Strategic Investing - Early Times

Fri, 26 Sep 2025
scPharmaceuticals Issues Promissory Note to MannKind - MSN

Mon, 22 Sep 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRY, SCPH, WKHS on Behalf of Shareholders - PR Newswire

Tue, 16 Sep 2025
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH - Business Wire

Mon, 25 Aug 2025
New Analyst Forecast: $SCPH Given 'Hold' Rating - Quiver Quantitative

Mon, 25 Aug 2025
SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 54 (M)
Shares Float 33 (M)
Held by Insiders 5.9 (%)
Held by Institutions 80.3 (%)
Shares Short 695 (K)
Shares Short P.Month 1,010 (K)
Stock Financials
EPS -1.81
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.41
Profit Margin -183.6 %
Operating Margin -89.2 %
Return on Assets (ttm) -57.1 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 99.1 %
Gross Profit (p.s.) 0.63
Sales Per Share 0.93
EBITDA (p.s.) -1.24
Qtrly Earnings Growth 0 %
Operating Cash Flow -66 (M)
Levered Free Cash Flow -42 (M)
Stock Valuations
PE Ratio -3.13
PEG Ratio 0
Price to Book value -14.13
Price to Sales 6.06
Price to Cash Flow -4.61
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android